CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

NCT07575867 · clinicaltrials.gov ↗

RECRUITING

Status

464

Enrollment

OTHER_GOV

Sponsor class

Conditions

Atrial Fibrillation
Stroke Prevention in Patients With Atrial Fibrillation
Left Atrial Appendage Closure
Hemorrhage
Anticoagulants / Administration & Dosage
Reduced-dose Apixaban
Thromboembolism

Interventions

DEVICE: Left Atrial Appendage Closure
DRUG: Apixaban 2.5 mg BID
DRUG: Standard-dose DOAC

Sponsor

National Medical Research Center for Therapy and Preventive Medicine